To determine the thermoregulatory effects of propofol and nitrous oxide, we measured the threshold for peripheral vasoconstriction in seven volunteers over a total of 13 study days. We also evaluated the effect of vasoconstriction on oxyhemoglobin saturation (Spo,). Anesthesia was induced with an intravenous bolus dose of propofol (2 mgkg), followed by an infusion of 180 pg.kg-'.min-* for 15 min, and maintained with 60% nitrous oxide and propofol(80-160 pg-kg-l-rnin-'). Central and skin surface temperatures and Spo, (using two different pulse oximeters) were measured continuously; plasma propofol concentrations and arterial Po, were measured at 15-min intervals. Volunteers were cooled with a circulating water blanket until definitive peripheral vasoconstriction was detected. The tympanic membrane temperature triggering vasoconstriction was considered the thermoregulatory threshold. Vasoconstriction developed on seven study days during propofolhitrous oxide anesthesia at a central temperature of 33.3 f 1.o"C (mean f SD) and plasma propofol concentration of 3.9 2 1.1 pg/mL. The thresholds during anesthesia were significantly lower than those during the control period (36.7 f 0.3"C), but the correlation between plasma propofol concentrations and vasoconstriction thresholds was poor. On the remaining six study days, vasoconstriction did not develop despite central temperatures ranging from 32.1 to 32.7"C. Corresponding propofol concentrations were 4.1-10.9 @mL. These data suggest that anesthesia with propofol, in typical clinical concentrations, and 60% nitrous oxide substantially inhibits thermoregulatory vasoconstriction. Vasoconstriction increased Spo, by approximately 2% without a sigruficant concomitant change in Po,. The observed increase in Spo2 probably reflects decreased transmission of arterial pulsations to venous blood in the finger. rane decrease the threshold for vasoconstriction in humans (i.e., the central temperature triggering vasoconstriction) by 1 3°C in a dose-dependent fashion Some intravenous anesthetics, including barbiturates (6), profoundly inhibit thermoregulatory responses in animals; others, such as ketamine (7,8), urethane (9,10), and fentanyYdroperido1 (ll), appear to have less effect. Barbiturates also appear to inhibit thermoregulatory responses in humans (12). Thermoregulatory effects of intravenous anesthetics have not been extensively investigated in humans, but fentanyl alone (13) and fentanyl combined with nitrous oxide (14) do inhibit responses. Propofol is a recently introduced anesthetic; however, the thermoregulatory consequences of its administration have not been quantified. Accordingly, we tested the hypothesis (2-5).
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that propofolhitrous oxide anesthesia inhibits thermoregulatory vasoconstriction in humans.
We (15) and others (16) have observed that thermoregulatory vasoconstriction increases oxyhemoglobin saturation (Spo,) 1%-2%. However, alterations in Spo, produced by thermoregulatory vasoconstriction have not been correlated with changes in arterial Po,. We therefore measured arterial Po, and Spo, (using two brands of pulse oximeter) and tested the hypothesis that thermoregulatory vasoconstriction increases systemic arterial Po,.
Methods
After receiving approval from the University of California, San Francisco, Committee on Human Research, we studied seven volunteers over a total of 13 study days. None of the volunteers was obese, taking medication, or had a history of thyroid disease, dysautonomia, or Raynaud's syndrome. Ambient temperature was maintained at 20.9 5 0.3"C (mean * SD) and ambient relative humidity at 42% k 3% throughout the study period (model HX93 humidity and temperature transmitter, Omega Engineering). The percentage of body fat in each volunteer was determined using infrared interactance (Futrex 1000, Futrex, Inc., Hagerstown, Md.) (17).
Study Protocol
Volunteers fasted during the 8 h preceding each study, which started at approximately 9:30 AM. All were minimally clothed and reclined on a standard operating room table covered by a full-length circulating water mattress set at 37°C (Blanketrol, Cincinnati Sub-Zero Products, Inc., Cincinnati, Ohio). An intravenous catheter was inserted into the left antecubital vein, and lactated Ringer's solution warmed to 37°C was infused at approximately 100 mL/h. A 20-gauge catheter was inserted into the left radial artery to permit sampling of blood for determination of circulating drug concentrations.
After a 15-min control period, anesthesia was induced without any premedication by administration of an intravenous bolus dose of propofol (ICI Americas, Inc., Wilmington, Del.) (2 mgikg), followed by an infusion of 180 pg.kg-'.min-' for 15 min. Neither thiopental nor opioids were administered. Vecuronium (10 mg IV) was administered to facilitate intubation of the trachea. Anesthesia was maintained with 60% nitrous oxide and an infusion of propofol at a rate of 80, 100, 120, or 160 pg. kg-lamin-' delivered by a Program 2 syringe pump (Becton Dickinson & Company, Lincoln Park, N. J.); maintenance infusion rates were kept constant throughout each study day. Different infusion rates were used to produce a range of clinically relevant blood propofol concentrations (18).
Four volunteers were studied on more than one day. Of these, two were studied with three different propofol infusion rates: 80, 100, and 160 pg.kg-'.mK'. One other volunteer was studied at 80 and 100 pg-kg-'. h -1 , and a fourth was studied at 120 and 160 pg-kg-l.
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Muscle relaxation was maintained with an infusion of vecuronium (Program 2 syringe pump) adjusted to maintain 0-1 twitches in response to supramaximal train-of-four electrical stimulation of the ulnar nerve at the wrist. Mechanical ventilation was adjusted to maintain end-tidal Pco, at 34 2 1 mm Hg, and inspired oxygen concentration was maintained at 30% (monitored by a Capnomac [Datex Medical Instrumentation, Inc., Tewksbury, Mass.]). Routine monitoring throughout the study included arterial blood pressure and heart rate.
After an initial 45 min, central hypothermia was induced by decreasing the circulating water blanket temperature to 10°C. Anesthesia was discontinued when (a) definitive thermoregulatory vasoconstriction was observed; (b) central temperature approached 32°C without evidence of developing vasoconstriction; or (c) 6 h of anesthesia elapsed.
Measurements
Temperatures were monitored continuously with Mon-a-Therm (St. Louis, Mo.) thermocouple probes connected to Mallinckrodt model 8700 (St. Louis, Mo.) two-channel electronic thermometers. One thermocouple probe was placed in contact with the tympanic membrane and the aural canal was carefully occluded with cotton. After induction of anesthesia, temperatures also were recorded from the distal fourth of the esophagus by means of a probe incorporated into an esophageal stethoscope. Because our study design required central temperature measurements before induction of anesthesia, we considered tympanic membrane temperatures to be representative of central tissues. We (3,19) and others (20, 21) have previously demonstrated an excellent correlation between distal esophageal and tympanic membrane temperatures. Skin temperature was measured at 10 sites and the area-weighted mean calculated by assigning the following regional percentages: head 6%, upper arms 9%, forearms 6%, hands 4.5%, back 1970, chest 9.5%, abdomen 9.5%, thigh 19%, calves 31.5%, and feet 6% (22).
Skin-temperature gradients were used to measure thermoregulatory vasoconstriction on the right arm. The gradient was calculated by subtracting fingertip skin temperature from midforearm skin temperature. Fingertip temperature can range from near ambient (vasoconstricted) to near core temperature (vasodila ted) because of the presence of thermoregulatory arteriovenous shunts and the wide range over which fingertip blood flow varies. Forearm skin does not possess arteriovenous shunts, and therefore its temperature is less affected by thermoregulatory status. We have previously demonstrated that forearm minus fingertip skin-temperature gradients correlate extremely well with volume plethysmography (the most reliable measure of peripheral blood flow) (23). There is also a fair correlation between skin temperature gradients and laser Doppler flowmetry (4,14). The right arm was kept well away from the circulating water blanket and had neither an intravenous catheter nor a blood pressure cuff. As in previous studies, a forearm minus fingertip skin-temperature gradient exceeding 4°C was considered definitive vasoconstriction (2, 3, 14) .
Fingertip Spo, was monitored continuously with Nellcor N200 (Hayward, Calif.) and Lifestat 1600 (Physio-Control, Redmond, Wash.) pulse oximeters placed on fingers of the right hand. Central and skin temperatures and Spo, were recorded at 5-min intervals using a previously described data-acquisition system (24).
Arterial blood samples were drawn at 15-min intervals, and Po, was determined using a calibrated Stat Pro 3 (Nova Biomedical, Waltham, Mass.) wholeblood gas analyzer. Blood for propofol determinations was centrifuged and the plasma stored frozen for later analysis. Samples were analyzed using highpressure liquid chromatography (PharmaKinetics Laboratories, Inc., Baltimore, Md.). This assay has an accuracy >O. 1 pg/mL for concentrations ranging from 0.1 to 5.0 pg/mL and an accuracy >0.2 pg/mL for concentrations ranging from 5.0 to 10.0 pg/mL.
Data Analysis
The thermoregulatory threshold for vasoconstriction was defined as the tympanic membrane (central) temperature at which definitive vasoconstriction was first observed. A data-base program was used to average the Spo, and Po, values in each volunteer during the 15-min epoch before and after vasoconstriction. Vasoconstriction thresholds before induction of anesthesia and during propofol/nitrous oxide administration were compared using two-tailed, paired t-tests. The correlation between vasoconstriction thresholds and blood propofol concentrations was evaluated using linear regression. Timedependent changes in Spo, and Po, were analyzed using repeated-measures analysis of variance and Dunnett's tests. Measurements obtained 10-20 min after vasoconstriction were used as the reference for determining statistically significant changes. Differ- ences were considered significant when P I 0.01. Results are reported as mean k SD.
Results
The mean age of the volunteers was 25.9 * 2 yr, weight 74 k 15 kg, height 176 * 7 cm, and body fat 19% * 3%. Tympanic membrane and distal esophageal temperatures were typically within 0.1"C and rarely differed by >0.2"C. All volunteers experienced vasoconstriction during the control period before induction of anesthesia. Vasoconstriction developed during propofollnitrous oxide anesthesia on 7 of the 13 study days at central temperatures between 32.3 and 34.7"C (mean 33.3 2 l.O°C) (Figure 1 ). The corresponding mean skin temperature was 27.2 2 l.O°C, and plasma propofol concentrations ranged from 2.1 to 5.6 pg/mL (mean 3.9 5 1.1 &mL). The vasoconstriction threshold during anesthesia on these seven study days was significantly lower than the threshold during the control period, when central temperature was 36.7 * 0.3"C and mean skin temperature was 31.1 * 0 . X .
The correlation between plasma propofol concentrations and thresholds for vasoconstriction was poor (Threshold = 35.1 -0.8 [Propofol] ; r = 0.53).
On the remaining six study days, vasoconstriction did not develop despite central hypothermia to between 32.1 and 327°C and mean skin temperatures of 27.9 2 1.6"C ( Figure 1 ). Plasma propofol concentrations measured at the lowest central temperature before rewarming were generally higher (6.2 2 2.6 j&mL [range 4.1-10.91) than those measured at the time of vasoconstriction during the other seven study days ( P = 0.053).
In those volunteers who were studied at more than one infusion rate, higher infusion rates were associated with increased plasma propofol levels and either lower thresholds for vasoconstriction or no vasoconstriction at all (Figure 1 ).
Arterial Po, and Spo, data from both oximeters were available on only five of the seven study days when vasoconstriction occurred. Thermoregulatory vasoconstriction increased Spo, 1.7% * 1.4% on the Nellcor N200 and 2.3% 2 1.6% on the Lifestat 1600. There were no significant changes in arterial Po2, arterial blood pressure, or heart rate at the time of vasoconstriction (Figure 2) .
Discussion
Physiologic responses to MAC-adjusted concentrations of various volatile anesthetics are more notable for their similarities than differences. For example, the thresholds for thermoregulatory vasoconstriction appear only slightly higher during halothane (2) than during isoflurane anesthesia (3). In contrast, thermoregulatory responses to intravenous anesthetics, sedatives, and hypnotics differ considerably (6,7,11,13), making it difficult to predict responses to a new drug without specific experimental evidence.
Our data indicate that anesthesia with propofol in typical clinical concentrations, combined with 60% nitrous oxide, substantially inhibits thermoregulatory vasoconstriction. Although the correlation between propofol concentration and vasoconstriction threshold calculated from the combined data was poor, a dose-dependent effect is apparent from the data obtained from those volunteers given more than one propofol infusion rate. Furthermore, plasma propofol concentrations were generally higher on study days when vasoconstriction did not develop than on days when it did. Presumably, vasoconstriction would have developed in all cases were volunteers permitted to become sufficiently hypothermic. For safety reasons, we rewarmed volunteers when their central temperatures reached 32°C. Clinically, it is rare for patients to become this hypothermic without deliberate cooling.
Poor correlation between propofol concentrations and vasoconstriction thresholds may have resulted because the apparently steep dose-response relationship allowed only a small number of data points to fall within the relatively narrow range of permissible central temperatures. Had we allowed central temperature to decrease sufficiently to trigger vasoconstriction in all cases, the correlation may have been better.
The range of thermoregulatory thresholds in those volunteers who experienced vasoconstriction during propofol/nitrous oxide anesthesia was 32.3-34.7"C, which is similar to the range of thresholds expected from administration of 0.8%-1.7% end-tidal isoflurane (3) and lower than the range observed during anesthesia with 0.86% halothane or 70% nitrous oxide and fentanyl4 pg-kg-l-h-' (2,14).
Nitrous oxide contributed approximately 0.6 MAC in these volunteers. Although nitrous oxide combined with fentanyl significantly inhibits thermoregulatory vasoconstriction (14), the effect of nitrous oxide alone on vasoconstriction has not specifically been determined. Subanesthetic partial pressures of nitrous oxide impair behavioral thermoregulatory responses in mice (25). Similarly, 30% nitrous oxide decreases the shivering threshold approximately 1°C in humans (26) . It is thus likely that nitrous oxide also inhibits thermoregulatory vasoconstriction; however, its contribution to the observed profound inhibition with propofol cannot be determined from our data.
The tympanic membrane is not an obvious site for measuring central temperature; it is a small structure, surrounded by air and does not have a particularly high blood flow. Tympanic membrane temperature measurements were popularized by Benzinger (27) in  1959. (In a remarkable investigation, he demonstrated the validity of tympanic membrane temperatures by having thermometers implanted into his own head!) Numerous subsequent studies have dem-onstrated superb correlations between distal esophageal and tympanic membrane temperatures ( 3 , W 21).
Many mammals possess specialized vascular systems that allow them to maintain a lower brain temperature than core temperature (28) . Recently, Cabanac and Caputa (29) have proposed that humans may also have specific brain cooling. The major support for this thesis is an observed decrease in tympanic temperature relative to distal esophageal temperature during heat stress and facial fanning (30, 31) . (The assumption in these studies is that the apparent relative decrease in tympanic membrane temperature represents true brain cooling, not simply an artifact of the measurement location.) However, even during these special circumstances, the distal esophageal to tympanic membrane temperature difference rarely exceeds 02°C. Under circumstances similar to our study (i.e., gradual cooling without facial fanning), the two temperatures usually are virtually identical.
Because of the observed small differences between tympanic membrane and other central temperature measurement sites under some circumstances, most physiologists now prefer distal esophageal temperatures. During general anesthesia, the distal esophagus is usually the easiest and most reliable central temperature monitoring site. However, during the control period, we recorded only tympanic membrane temperatures because esophageal probes would have been uncomfortable for unanesthetized subjects. Consequently, the vasoconstriction thresholds in this study are reported in terms of tympanic membrane temperature to minimize systematic errors. In any case, potential errors in our central temperature measurements are of little consequence compared with the range of thresholds observed in this study.
Our volunteers were not undergoing surgery or comparable pain. Painful stimulation provided by a 100-Hz current increases the thermoregulatory threshold only approximately 0.4"C during enflurane anesthesia (32) . However, the extent to which pain and subsequent autonomic activation contribute to thermoregulatory responses during propofoYnitrous oxide anesthesia remains unknown. Therefore, our current results may not necessarily apply to patients during surgery. Nevertheless, in patients whose surgical pain is prevented by regional anesthesia, propofoYnitrous oxide anesthesia would likely produce similar thermoregulatory inhibition.
As in our previous study (15), fingertip pulse oximetry significantly increased Spo,. Mean arterial blood pressure remained within the normal range during our study and did not change significantly during vasoconstriction. We have already demonstrated that pulse oximeters continue to function well, even when arterial inflow (33) or venous outflow (34) is substantially reduced.
Systemic or local pulmonary hypothermia impairs hypoxic pulmonary vasoconstriction (35) and would be expected to increase pulmonary shunt and decrease arterial Po,. However, we speculated that pulmonary blood flow distribution may be altered in conjunction with the activation of thermoregulatory peripheral vasoconstriction, thus leading to an actual increase in arterial Po,. Nevertheless, our data indicate that no significant changes in arterial Po, occurred. It is therefore unlikely that the increase in Spo, observed with both oximeters resulted from a systemic effect of hypothermia.
More likely, the increase in Spo, was caused by a decrease in the venous pulsatile signal resulting from the closure of arteriovenous shunts, as proposed by Kelleher and Ruff (16) . Normal (vasodilated) finger blood flow exceeds nutritive requirements more than 10-fold, with most of the volume traversing arteriovenous shunts (36) . Because these are relatively large vessels (100 pm), it is likely that arterial pulsations extend to venules just distal to the shunts. However, some of this distal blood is desaturated (having passed through capillaries) and will reduce the apparent arterial saturation (37). After vasoconstriction, fingers resemble most other tissues in that arterial pulsations do not extend to the venous circulation, and pulsatile flow is nearly entirely arterial. As pulse oximeters detect only pulsatile flow, apparent saturation would increase after vasoconstriction.
Manufacturers of pulse oximeters calibrate their devices empirically using data obtained from human subjects. Our results suggest that this calibration would be affected by the thermoregulatory status of those volunteers. It is important to note that this approximately 2% effect may be seen in a large percentage of patients recovering from general anesthesia, because even mild intraoperative hypothermia usually produces intense vasoconstriction on arrival in the postanesthesia care unit.
In summary, on 7 of 13 study days, vasoconstriction developed during propofoYnitrous oxide anesthesia at central temperatures of 33.3 k 1.O"C and plasma propofol concentrations of 3.9 * 1.1 pg/mL.
Vasoconstriction thresholds during anesthesia were significantly lower than those during the control period (36.7 ? 0.3"C), but the correlation between plasma propofol concentrations and these thresholds was poor. On the remaining six study days, vasoconstriction did not develop, even though central temperatures ranged from 32.1 to 32.7"C, with propofol concentrations of 4.1-10.9 pg/mL. Fingertip Spo, measured with two different pulse oximeter models increased approximately 2% during thermoregula-tory vasoconstriction without a concomitant increase in arterial Po2. We conclude that general anesthesia with typical clinical concentrations of propofol combined with 60% nitrous oxide substantially inhibits thermoregulatory vasoconstriction and that vasoconstriction artifactually increases Spo,.
